Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

AngelMed’s implantable device (left) alerts high-risk patients when they show signs of a heart attack and could help them get medical attention sooner. Whereas existing implantable devices are designed to detect electrical irregularities in the heart, known as arrhythmias, this device uses novel algorithms to detect problems with blood flow. The device picks up a subtle abnormality in electrical current that occurs when one of the coronary arteries is blocked by a clot. When the device detects these signs of heart attack, it generates a buzz that the patient can feel, alerting him or her to call 911. Approved in Brazil, the device is undergoing clinical testing in the United States.

Product: AngelMed Guardian System
Cost: Not available
Source: www.angel-med.com
Company: AngelMed

Credit: Courtesy of Angelmed

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me